BR112022017192A2 - Variantes de transglutaminase - Google Patents
Variantes de transglutaminaseInfo
- Publication number
- BR112022017192A2 BR112022017192A2 BR112022017192A BR112022017192A BR112022017192A2 BR 112022017192 A2 BR112022017192 A2 BR 112022017192A2 BR 112022017192 A BR112022017192 A BR 112022017192A BR 112022017192 A BR112022017192 A BR 112022017192A BR 112022017192 A2 BR112022017192 A2 BR 112022017192A2
- Authority
- BR
- Brazil
- Prior art keywords
- variants
- transglutaminase
- transglutaminase variants
- preservatives
- applications
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/104—Aminoacyltransferases (2.3.2)
- C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00041—Use of virus, viral particle or viral elements as a vector
- C12N2795/00043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/02—Aminoacyltransferases (2.3.2)
- C12Y203/02013—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
VARIANTES DE TRANSGLUTAMINASE. A presente invenção refere-se a variantes de Transglutaminase. Aplicações de uso para as variantes, incluindo o uso como conservantes, agentes biocidas e para modificação de proteínas, são divulgadas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202062988918P | 2020-03-13 | 2020-03-13 | |
PCT/US2021/021766 WO2021183680A1 (en) | 2020-03-13 | 2021-03-10 | Transglutaminase variants |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112022017192A2 true BR112022017192A2 (pt) | 2022-10-18 |
Family
ID=77671938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112022017192A BR112022017192A2 (pt) | 2020-03-13 | 2021-03-10 | Variantes de transglutaminase |
Country Status (9)
Country | Link |
---|---|
US (1) | US20230167420A1 (pt) |
EP (1) | EP4118194A1 (pt) |
JP (1) | JP2023518714A (pt) |
KR (1) | KR20220153047A (pt) |
CN (1) | CN115298306A (pt) |
BR (1) | BR112022017192A2 (pt) |
CA (1) | CA3172844A1 (pt) |
MX (1) | MX2022011077A (pt) |
WO (1) | WO2021183680A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023225666A1 (en) | 2022-05-20 | 2023-11-23 | Curie Co. Inc. | Pro-peptide variants for modulating activity of transglutaminases |
CN115487345B (zh) * | 2022-08-22 | 2024-03-12 | 天津大学 | 基于丝素蛋白的止血水凝胶和止血海绵及其制备方法和应用 |
CN117643311A (zh) * | 2023-12-01 | 2024-03-05 | 北京舜雷科技有限公司 | 一种组合物、制备方法及应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1310560A4 (en) * | 2000-08-17 | 2005-07-13 | Ajinomoto Kk | METHOD FOR MODIFICATION OF TRANSGLUTAMINASE OF MICROORGANISMS (MTG) |
WO2007020290A1 (en) * | 2005-08-18 | 2007-02-22 | Novo Nordisk Health Care Ag | Transglutaminase variants with improved specificity |
-
2021
- 2021-03-10 KR KR1020227034975A patent/KR20220153047A/ko unknown
- 2021-03-10 JP JP2022554747A patent/JP2023518714A/ja active Pending
- 2021-03-10 US US17/910,952 patent/US20230167420A1/en active Pending
- 2021-03-10 WO PCT/US2021/021766 patent/WO2021183680A1/en unknown
- 2021-03-10 EP EP21768309.3A patent/EP4118194A1/en active Pending
- 2021-03-10 MX MX2022011077A patent/MX2022011077A/es unknown
- 2021-03-10 BR BR112022017192A patent/BR112022017192A2/pt unknown
- 2021-03-10 CA CA3172844A patent/CA3172844A1/en active Pending
- 2021-03-10 CN CN202180019827.5A patent/CN115298306A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
EP4118194A1 (en) | 2023-01-18 |
CA3172844A1 (en) | 2021-09-16 |
KR20220153047A (ko) | 2022-11-17 |
WO2021183680A1 (en) | 2021-09-16 |
CN115298306A (zh) | 2022-11-04 |
US20230167420A1 (en) | 2023-06-01 |
JP2023518714A (ja) | 2023-05-08 |
MX2022011077A (es) | 2022-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112022017192A2 (pt) | Variantes de transglutaminase | |
BR112021024224A2 (pt) | Inibidores de tead e usos dos mesmos | |
CO2018003973A2 (es) | Proteínas de unión a pd-1 y métodos para usarlas | |
EP4234689A3 (en) | Split inteins with exceptional splicing activity | |
EA201792583A1 (ru) | Способы и композиции для ингибирования взаимодействия менина с белками mll | |
BR112018010118A2 (pt) | inibidores de cxcr2 | |
BR112021019748A2 (pt) | Degradadores de stat e usos dos mesmos | |
CL2018000107A1 (es) | Moléculas de anticuerpo que se unen a cd79 | |
CY1124761T1 (el) | Ρυθμιστες της δραστικοτητας του συμπληρωματος | |
EA201890079A1 (ru) | Клеточная система для направленной доставки активного ингредиента | |
CO2018006521A2 (es) | Compuestos de benzamida y sus usos como herbicidas | |
BR112019000693A2 (pt) | composições de muc1- car e métodos para uso | |
BR112019012796A2 (pt) | proteínas de ligação ao antígeno antineuropilina e métodos de uso das mesmas | |
EA202090540A1 (ru) | Ген, придающий устойчивость к патогенному грибу | |
BR112014002817A2 (pt) | Uso de um polipeptídeo p62, ou de um ácido nucleico que codifica p62 | |
CL2017002856A1 (es) | Compuestos de tioéter como inhibidores de la nitrificación | |
MX2021008592A (es) | Composiciones de trem y usos de las mismas. | |
BR112022012410A2 (pt) | Degradadores smarca e usos dos mesmos | |
EA201892500A1 (ru) | Применение фракции лигнина в качестве антифитопатогенного агента и содержащие ее антифитопатогенные композиции | |
BR112018014355A2 (pt) | processos para a preparação de f-benzoxazinorifamicina i e para a preparação de 2-amino-5-fluorobenzeno-1,3-diol iii | |
BR112021016056A2 (pt) | Anticorpos de claudina 6 e usos dos mesmos | |
BR112018071592A2 (pt) | inibidores de erbb e usos dos mesmos | |
BR112022018678A2 (pt) | Degradadores de mdm2 e usos dos mesmos | |
CO2023000510A2 (es) | Mezclas fungicidas | |
BR112014028130A2 (pt) | Sal de cloridrato de um peptídeo, composição farmacêutica, uso de um sal de cloridrato, uso de uma composição farmacêutica, e, método para evitar ou tratar alergia a gatos |